Rotenone was also able to alter DNA methylation in the proximity of CTCF binding sites, with CTCF being a regulatory protein that binds DNA to control spatial organization and transcription, in genes associated with PD, including PARK2 [113]. Here, PRKN is linked to Parkinson disease.